Moderna starts trial testing Omicron-specific COVID-19 booster shot

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

WASHINGTON: US biotech company Moderna announced on Wednesday (Jan 26) that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus. The trials will involve a total of 600 adults - half of whom have already received two doses of

WASHINGTON: US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.

The company also reported results on the efficacy against Omicron of the booster that has already been authorised. "We are reassured by the antibody persistence against Omicron at six months after the currently authorised" booster, Moderna chief executive Stephane Bancel said in the statement.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna starts study of Omicron-specific Covid-19 vaccine booster
Source: STForeignDesk - 🏆 4. / 71 Read more »

Pfizer and BioNTech launch trial of Omicron-targeted COVID-19 vaccineNEW YORK: Pfizer and BioNTech said on Tuesday (Jan 25) they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen. The companies plan to test the
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Pfizer and BioNTech launch trial of Omicron-targeted Covid-19 vaccineOmicron targeted vaccine by Pfizer ScottMorrisonMP GregHuntMP BradHazzard ChrisMinnsMP
Source: STForeignDesk - 🏆 4. / 71 Read more »

Pfizer and BioNTech launch trial of Omicron-targeted Covid-19 vaccineNEW YORK - Pfizer Inc and BioNTech SE said on Tuesday (Jan 25) they started a clinical trial to test a new version of their vaccine specifically designed to target the Covid-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen. Banking on volunteers in the United States, the companies plan to test...
Source: asiaonecom - 🏆 10. / 59 Read more »

Covid-19 variant Omicron can survive up to 21 hours on skin: Study
Source: STForeignDesk - 🏆 4. / 71 Read more »

Beijing's local Covid-19 cases rise before Olympics; more areas find OmicronBEIJING — Beijing reported 14 local confirmed Covid-19 cases on Wednesday (Jan 26), the highest daily count in its current outbreak, less than two weeks before the Winter Olympics are set to start in the Chinese capital and the neighbouring province of Hebei.
Source: TODAYonline - 🏆 1. / 99 Read more »